This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978
Title: The Innovations of Karl Credner
Introduction
Karl Credner is a notable inventor based in Kaarst, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his work on adenine derivatives. His innovative approach has led to advancements in hypolipidemic compositions, which are essential for managing lipid levels in the body.
Latest Patents
Credner holds a patent for "Adenine derivatives and hypolipidemic composition thereof." This patent details the preparation of adenine derivatives and their pharmaceutical compositions, which are designed to effectively induce hypolipidemia. Notably, these derivatives are characterized by their lack of inhibition on C-AMP-phosphodiesterase, making them a unique addition to the pharmaceutical landscape. He has 1 patent to his name.
Career Highlights
Throughout his career, Credner has focused on the development of innovative pharmaceutical solutions. His work has not only contributed to scientific knowledge but has also paved the way for new treatments in the medical field. His dedication to research and development has established him as a respected figure in the industry.
Collaborations
Credner has collaborated with notable professionals in his field, including Manfred Tauscher and Ljerka Jozic. These partnerships have enhanced his research efforts and contributed to the successful development of his patented innovations.
Conclusion
Karl Credner's contributions to the field of pharmaceuticals through his innovative work on adenine derivatives highlight the importance of research and collaboration in advancing medical science. His patent serves as a testament to his dedication and expertise in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile